These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 35916537)
1. Microbiome-metabolome analysis insight into the effects of high-salt diet on hemorheological functions in SD rats. Qi L; Li Y; Chen Z; Wei C; Wen X; Hu S; Wu H; Lv Z; Xu Z; Xia L Front Nutr; 2024; 11():1408778. PubMed ID: 39381352 [TBL] [Abstract][Full Text] [Related]
2. Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices. Musick JO; Fibben KS; Lam WA Curr Opin Hematol; 2022 Nov; 29(6):290-296. PubMed ID: 35916537 [TBL] [Abstract][Full Text] [Related]
3. Introduction to hemorheology: theoretical aspects and hyperviscosity syndromes. Stoltz JF; Donner M; Larcan A Int Angiol; 1987; 6(2):119-32. PubMed ID: 3323349 [TBL] [Abstract][Full Text] [Related]
4. Increased plasma viscosity in plasma cell dyscrasia and whole blood viscosity in polycythemia vera. Shin DW; Gu JY; Kim JS; Jung JS; Shin DY; Koh Y; Kim I; Kim HK Clin Hemorheol Microcirc; 2018; 70(1):59-67. PubMed ID: 29660912 [TBL] [Abstract][Full Text] [Related]
5. [Fundamental data in hemorheology. II. Hyperviscosity syndromes]. Stoltz JF Biomed Pharmacother; 1985; 39(6):282-92. PubMed ID: 3910128 [TBL] [Abstract][Full Text] [Related]
6. Hyperviscosity as a complication in a variety of disorders. Rampling MW Semin Thromb Hemost; 2003 Oct; 29(5):459-65. PubMed ID: 14631545 [TBL] [Abstract][Full Text] [Related]
8. The effect of Bruton's tyrosine kinase inhibitor ibrutinib on atherothrombus formation under stenotic flow conditions. Karel MFA; Tullemans BME; D'Italia G; Lemmens TP; Claushuis TAM; Kuijpers MJE; Cosemans JMEM Thromb Res; 2022 Apr; 212():72-80. PubMed ID: 35247800 [TBL] [Abstract][Full Text] [Related]
9. A microfluidic-informatics assay for quantitative physical occlusion measurement in sickle cell disease. Zhang X; Chan T; Carbonella J; Gong X; Ahmed N; Liu C; Demandel I; Zhang J; Pashankar F; Mak M Lab Chip; 2022 Mar; 22(6):1126-1136. PubMed ID: 35174373 [TBL] [Abstract][Full Text] [Related]
10. Increased blood viscosity and red blood cell aggregation in patients with COVID-19. Nader E; Nougier C; Boisson C; Poutrel S; Catella J; Martin F; Charvet J; Girard S; Havard-Guibert S; Martin M; Rezigue H; Desmurs-Clavel H; Renoux C; Joly P; Guillot N; Bertrand Y; Hot A; Dargaud Y; Connes P Am J Hematol; 2022 Mar; 97(3):283-292. PubMed ID: 34939698 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Grobbelaar LM; Venter C; Vlok M; Ngoepe M; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34328172 [TBL] [Abstract][Full Text] [Related]
12. Polycythemia Vera Presenting as Hemorrhagic Stroke. Balagopal K; Mathew A; Koshy AG; Jacob JP J Neurosci Rural Pract; 2021 Jul; 12(3):601-602. PubMed ID: 34295120 [TBL] [Abstract][Full Text] [Related]
13. Exploitation of blood non-Newtonian properties for ultrasonic measurement of hematocrit. Pialot B; Gachelin J; Provost J; Couture O Sci Rep; 2021 May; 11(1):10208. PubMed ID: 33986398 [TBL] [Abstract][Full Text] [Related]
14. Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation. Mungmunpuntipantip R; Wiwanitkit V Clin Appl Thromb Hemost; 2021; 27():10760296211006779. PubMed ID: 33906462 [No Abstract] [Full Text] [Related]